Patient Counseling in the USA: It's a Legal Requirement, How to Counsel Patients on New Prescriptions to Meet Omnibus Budget Reconciliation Act (OBRA '90) standards.

Patient Counseling in the USA: It’s a Legal Requirement, How to Counsel Patients on New Prescriptions to Meet Omnibus Budget Reconciliation Act (OBRA ’90) standards.

by

Patient counseling for new prescriptions is not optional in the United States. It is a legal and clinical duty. The Omnibus Budget Reconciliation Act of 1990 (OBRA ’90) created a national baseline: pharmacists must offer counseling to Medicaid patients and conduct a prospective drug utilization review (pro-DUR) before dispensing. Most states went further and require an offer to counsel for every patient, with specific content and documentation rules. This guide shows exactly what to cover and how to deliver counseling that meets OBRA ’90 standards and stands up to audits—while actually helping patients use their medicines safely.

What OBRA ’90 Requires (and What States Added)

OBRA ’90 core duties include two parts:

  • Offer to counsel for new prescriptions (originals) for Medicaid patients. The offer can be written, verbal, or by signage, but the goal is to start a real conversation. Why: patients make fewer errors when they hear clear instructions and can ask questions.
  • Prospective DUR before dispensing. You must check for therapeutic duplication, drug–disease or drug–drug interactions, incorrect dose or duration, allergies, abuse or misuse. Why: catching issues early prevents harm and liability.

What states commonly added (check your board rules):

  • Offer to counsel for all patients, not just Medicaid.
  • Actual counseling must be provided if the patient accepts. Pharmacy technicians generally cannot counsel; a pharmacist or supervised intern must do it. Why: counseling involves clinical judgment.
  • Content requirements that mirror OBRA ’90 (see next section).
  • Documentation of the offer, acceptance or refusal, and counseling provided. Why: if it isn’t documented, it didn’t happen—especially in audits or after an adverse event.
  • Refusal must be by the patient or caregiver. A blanket “no counseling” policy is not compliant.

Core Counseling Elements You Must Cover

For a new prescription, cover these OBRA ’90 elements in plain language. Each item reduces a known risk:

  • Name and purpose of the medication. Why: patients take meds correctly when they know what each one does.
  • Dosage form, strength, route, and schedule. Use specific timing cues (e.g., “morning with breakfast”). Why: vague directions lead to missed or double doses.
  • Duration of therapy. State when to stop or expect benefit. Why: prevents premature stopping or unnecessary continuation.
  • Special directions and precautions. Food effects, activities to avoid, device use. Why: many errors involve timing with meals or misuse of inhalers, pens, or patches.
  • Common side effects and serious warning signs that require urgent care. Why: patients often stop meds due to expected, manageable effects, or miss serious red flags.
  • Drug and lifestyle interactions. Include OTCs, supplements, alcohol, and key foods. Why: hidden interactions cause preventable harm.
  • Contraindications or key health conditions to discuss with the prescriber. Why: changes may be needed for pregnancy, kidney or liver disease.
  • Self-monitoring parameters if relevant (e.g., blood pressure, glucose, weight). Why: feedback guides adherence and detects problems.
  • Storage and disposal. Include temperature, moisture, light, and safe disposal basics. Why: potency and safety depend on storage.
  • Refill information and what to do if a dose is missed. Why: missed dose plans prevent double dosing or abandonment.

These elements match OBRA ’90 and typical state rules. Use teach-back to confirm understanding.

Step-by-Step Counseling Process for a New Prescription

  • 1) Prepare: run a DUR. Verify allergies, diagnosis, dose, interactions, renal/hepatic adjustments, and duplicate therapy. Note key counseling points based on the patient’s profile. Why: you must resolve problems before you counsel.
  • 2) Start private and patient-centered. Move to a semi-private area. Confirm patient identity and preferred language. Offer an interpreter if needed. Why: privacy supports open questions and HIPAA compliance.
  • 3) Ask what they know. “What did your prescriber tell you this is for?” “How will you take it?” Why: builds on their understanding and reveals gaps without shaming.
  • 4) Explain the medicine. Cover the core elements: name/purpose, how and when to take, duration, special directions, common and serious side effects, interactions, monitoring, storage, refills, missed dose plan. Keep it short, concrete, and tailored.
  • 5) Use teach-back. “Just to make sure I explained it clearly, how will you take this?” Why: teach-back predicts understanding better than “Do you have questions?”
  • 6) Address barriers. Ask about cost, swallowing issues, device use, schedule fit, transportation, and health literacy. Offer solutions: synchronization, 90-day supplies, easier forms, adherence packaging. Why: adherence is often logistical.
  • 7) Close the loop. Repeat the top two risks and their action steps. Provide written points in plain language. Invite follow-up by phone. Why: repetition improves recall.
  • 8) Document. Record acceptance or refusal, content covered, interventions, communications with prescriber, and education materials given. Why: creates a defensible record.

What to Say: Plain-Language Examples

  • Amoxicillin 500 mg, three times daily for 7 days
    Purpose: “This is an antibiotic for your sinus infection.”
    How to take: “Take one capsule every 8 hours, like 7 am, 3 pm, 11 pm. With or without food. Finish all 7 days even if you feel better.”
    Common effects: “You may have mild stomach upset or loose stools. That’s common.”
    Serious signs: “If you get a rash, trouble breathing, or swelling, that’s an emergency.”
    Interactions: “Tell me if you use warfarin or methotrexate. Space probiotics at least 2 hours away.”
    Missed dose: “Take it when you remember unless it’s close to the next time. Don’t double up.”
  • Lisinopril 10 mg once daily
    Purpose: “This lowers blood pressure and protects your kidneys and heart.”
    How to take: “Take one tablet at the same time daily. Morning works well.”
    Common effects: “You may feel lightheaded when starting. Rise slowly.”
    Serious signs: “Call right away for swelling of lips or face, or if your cough becomes persistent.”
    Monitoring: “Check your pressure a few times a week at first. Bring readings to your doctor.”
    Interactions: “Avoid potassium supplements or salt substitutes unless your doctor says so.”
  • Metformin 500 mg with evening meal, then increase
    Purpose: “This helps your body use insulin better to lower blood sugar.”
    How to take: “Start with one tablet with your largest meal to reduce stomach upset. Your dose may increase after a week.”
    Common effects: “Gas or loose stools are common at first and usually improve.”
    Serious signs: “If you have severe vomiting, muscle pain, or trouble breathing, seek care.”
    Monitoring: “Check your glucose as directed. Watch for low blood sugar if you’re on other diabetes meds.”
    Precautions: “Hold it and call your doctor if you get contrast dye for scans, or if you have severe dehydration.”

Handling Special Situations

  • Low literacy or limited English. Use an interpreter. Speak slowly. Use visuals and simple words. Avoid jargon. Why: understanding, not volume, drives safety.
  • Caregivers and minors. Counsel the caregiver. Verify authority to receive PHI. Provide written summaries for home use. Why: they manage the day-to-day dosing.
  • Mail-order, phone, or telepharmacy. You still must offer counseling. Call the patient. Use video if available for inhalers, insulin pens, or injection training. Document the offer and outcome.
  • High-risk medications. For opioids, discuss overdose risk, sedation, alcohol avoidance, secure storage, and offer naloxone. For anticoagulants, emphasize bleeding signs, INR/monitoring, and drug–food interactions. For insulin and inhalers, demonstrate and observe technique. Why: these drugs have narrow safety margins.
  • Pregnancy/breastfeeding. Confirm status. Discuss risks and safer alternatives as needed. Coordinate with prescriber. Why: teratogens and milk transfer change counseling priorities.
  • Elderly or polypharmacy. Review fall risk, anticholinergic load, and simplified schedules. Consider pill organizers or blister packs. Why: complexity drives errors.

Documentation That Stands Up to Audits

  • Record the offer to counsel and the patient’s response (accepted or refused). If refused, note that it was an informed refusal.
  • Note the counselor’s name and role. Pharmacist or intern under supervision.
  • Summarize content covered: indication, directions, major side effects, interactions, monitoring, storage, missed dose. Use checkboxes if your system has them.
  • Capture DUR actions: alerts reviewed, outcomes, prescriber contacts, dose changes, and patient education provided.
  • Special factors: interpreter used, caregiver identity, privacy accommodation, device training performed.
  • Education materials given (leaflets do not replace oral counseling but can supplement it).

Why this matters: thorough documentation proves compliance, supports billing, and defends care if outcomes are questioned later.

Common DUR Flags and How to Resolve

  • Duplicate therapy: Two ACE inhibitors, two statins. Confirm prescriber intent; adjust to one agent.
  • Drug–drug interactions: Amiodarone with simvastatin; macrolide with warfarin; linezolid with SSRIs. Propose safer alternatives or monitoring plans.
  • Dose too high/low or wrong duration: Renal dosing for metformin, DOACs, antibiotics. Recalculate with current labs; recommend changes.
  • Allergy or cross-sensitivity: Penicillin allergy with amoxicillin. Clarify reaction type; consider cephalosporin risk vs. benefit or non-beta-lactam.
  • High-risk combinations: Opioid plus benzodiazepine. Discuss taper plans, naloxone, and prescriber notification.
  • Early refills/overuse: Evaluate adherence, misuse, or therapy failure; coordinate with prescriber.

Always resolve DUR issues before counseling. Then incorporate the resolution into your counseling so the patient understands the plan.

Avoid These Pitfalls

  • Letting printed leaflets replace oral counseling. Patients remember conversations, not paper.
  • Asking only yes/no questions. Use open-ended and teach-back to check understanding.
  • Using jargon (“q.i.d.,” “prn,” “antagonist”). Translate to plain language.
  • Rushing. Two focused minutes beats 30 seconds of speed talk.
  • Ignoring privacy. Move away from the counter; protect PHI.
  • Skipping serious side effects and action steps. Patients need to know when to call for help.
  • Failing to document. No record means no proof of compliance.

Quick Checklist You Can Use Today

  • Offer to counsel and move to a private area.
  • Confirm identity, language, allergies, and purpose for use.
  • Name/purpose; how to take; when to stop or reassess.
  • Key side effects (common vs. serious) and what to do.
  • Interactions and precautions (OTCs, alcohol, foods, devices).
  • Monitoring, storage, refills, missed dose plan.
  • Address cost/adherence barriers; provide tools.
  • Use teach-back; invite questions.
  • Document offer, counseling, and DUR actions; record refusal if applicable.

The law set the floor. Your counseling sets the standard. When you follow OBRA ’90 content, close the loop with teach-back, and document well, you protect patients and your practice—and you make every new prescription safer and more effective.

Leave a Comment